Mimetogen
Montreal, CA · 1 known investors
Find your way into Mimetogen
Mimetogen is a biotechnology company developing novel therapeutics, with a focus on tavilermide for ophthalmic indications including dry eye disease. The company brings together expertise in drug discovery, development, and clinical research to advance treatment options in ophthalmology.
Founders & leadership
DB
Dr. BrazzellChief Medical Officer
FM
François MongraininChief Executive and Financial Officer
KM
Karen MeerovitchinSr Vice-President and Chief Development Officer
Board
KG
Kevin GieseExecutive Chairman of the Board
SA
Steven A. PeposeChief Medical Advisor
Investors · 1
In the news
Frequently asked questions
- What does Mimetogen do?
- Mimetogen is a biotechnology company developing novel therapeutics, with a focus on tavilermide for ophthalmic indications including dry eye disease. The company brings together expertise in drug discovery, development, and clinical research to advance treatment options in ophthalmology.
- Who are Mimetogen's investors?
- Mimetogen's investors include Schooner Capital.
- Where is Mimetogen headquartered?
- Mimetogen is headquartered in Montreal, CA.